Expressão de p53 e receptor de estrogênio em linfoma de hodgkin

Detalhes bibliográficos
Ano de defesa: 2007
Autor(a) principal: Miranda, Nadjane Barbosa de Amorim
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Dissertação
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Não Informado pela instituição
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: http://www.repositorio.ufc.br/handle/riufc/1782
Resumo: Hodgkin’s lymphoma is a entity where free disease and overal survive is prolonged by treatment and its molecular basis have been studied. In previus literature is described p53 as a protein that controls progress of celular cicle and TP 53 gene mutations prolong half-life of protein, modifing the mechanisms of apoptosis and regulation of celular proliferation. About of 50% of human cancers have TP53 mutations and the investigators believe that in the others the signaling mechanisms of p53 are altered by others ways. Hodgkin’s lymphoma cells stain for p53 frequently, but detection for TP53 gene mutation is rare. It’s not be well stabilished if p53 is a prognostic factor in Hodgkin’s lymphoma. There is no trial about p53 expression on Hodgkin’s lymphoma in Ceará state. Estrogen receptor were detected by imuno-histochemical analysis in normal bone marrow cells and others non-hematopoietic tissues. There is evidence that estrogen have a role on differentiation of B-cells and on regulation of apoptosis. If is Hodgkin’s lymphoma(HL) a B-cell neoplasm, with immune response seems to contribute in its pathogeny, its interesting to study the role of estrogen on Hodgkin’s lymphoma and its influence on this neoplasm behavior. We studied p53 and estrogen receptor expression in Hodgkin’s lymphoma on Ceará state. Were studied 39 cases of Hodgkin’s lymphoma confirmed by histo-pathological studies and by immuno-histochemical analysis and a control group with 10 cases of benign linfonodal hyperplasia. The simples were stained with p53 and estrogen receptor(ER) α anti-bodies. The age of patitens varied between 5 and 63 years, 21% were males, the initial presentation of disease was cervical adenopathy on 59% of cases and B simptoms were present on 56% of patients. On classification by histological subtipes, 56% were classical HL nodular sclerosis, 27% mixed cellularity, 14% lymphocyte-rich and 3% were HL linfocyte predominance. In this sample, lymphocyte-depleted subtype was not found. Positive staining for p53 occurred on 53% of cases and 10% of control group. Estrogen receptor was negative in all cases of Hodgkin’s lymphoma, but showed positive stainning in neutrophilic cells. In control group was founded ER positivity in 80% of cases, in histiocytic cells, with para-nuclear stainning and cytoplasmic diffuse. In conclusion, p53 expression occurs in more than 50% of Hodgkin’s lymphoma cases, as described previously, and there is expression of ERα in lymphoid tissue, but not on HL. There is persistent positivity in neutrophil cytoplasma. Another investigations are necessary to avaliate ERα and ERβ on RS cells and their role on the pathogenesis of Hodgkin’s lymphoma.